PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A.

Income Statement Profarma Distribuidora de Produtos Farmacêuticos S.A.

Stocks

PFRM3

BRPFRMACNOR1

Pharmaceuticals

Market Closed - Sao Paulo 01:33:00 13/08/2026 am IST			5-day change	1st Jan Change
6.990 ^BRL	-0.14%		-1.41%	-23.44%

30/07	Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07/05	Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

8adc7f7cb3371b4.Tgyo21d2LvzqKV4GQal1_6ea1xM1zgQnTcTenwvWIKU.KVqbqwJAe8-CYBA2Ns5FptGiunRRiWZzDvGB71y3SJ13RPK5ZCFCr9x_Dw

Published financial data: PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	641.32Cr	781.62Cr	866.17Cr	1.02TCr	1.15TCr
Total Revenues	641.32Cr	781.62Cr	866.17Cr	1.02TCr	1.15TCr
Cost of Goods Sold, Total	550.56Cr	667.07Cr	736.98Cr	863.08Cr	970.01Cr
Gross Profit	91Cr	114.55Cr	129.2Cr	152.28Cr	175.04Cr
Selling General & Admin Expenses, Total	67Cr	78Cr	104.64Cr	122.5Cr	136.88Cr
Provision for Bad Debts	-16.87L	8L	-	-	-
Depreciation & Amortization - (IS)	11Cr	13Cr	-	-	-
Other Operating Expenses	-96.36L	-1.51Cr	-1.55Cr	-17.93L	3.15Cr
Other Operating Expenses, Total	77Cr	89Cr	103.08Cr	122.32Cr	140.03Cr
Operating Income	14Cr	25Cr	26Cr	30Cr	35Cr
Interest Expense, Total	-7.62Cr	-15Cr	-16Cr	-15Cr	-20Cr
Interest And Investment Income	48.96L	86.79L	1.1Cr	82.95L	1.45Cr
Net Interest Expenses	-7.13Cr	-14Cr	-15Cr	-14Cr	-19Cr
Income (Loss) On Equity Invest.	59.76L	-7T	11T	35T	-2L
Other Non Operating Income (Expenses)	-1.07Cr	-2.35Cr	-2.86Cr	-3.07Cr	-4.59Cr
EBT, Excl. Unusual Items	6.03Cr	8.98Cr	8.16Cr	13Cr	12Cr
Impairment of Goodwill	-1.15Cr	-1.08Cr	-	-	-
EBT, Incl. Unusual Items	4.87Cr	7.9Cr	8.16Cr	13Cr	12Cr
Income Tax Expense	-3.04Cr	-60.7L	37.35L	50.48L	-85.51L
Earnings From Continuing Operations	7.91Cr	8.5Cr	7.79Cr	12Cr	13Cr
Net Income to Company	7.91Cr	8.5Cr	7.79Cr	12Cr	13Cr
Minority Interest	-9L	-41.66L	-74.61L	-82.34L	-71.15L
Net Income - (IS)	7.82Cr	8.09Cr	7.04Cr	11Cr	12Cr
Net Income to Common Incl Extra Items	7.82Cr	8.09Cr	7.04Cr	11Cr	12Cr
Net Income to Common Excl. Extra Items	7.82Cr	8.09Cr	7.04Cr	11Cr	12Cr
Per Share Items
Net EPS - Basic	0.64	0.66	0.57	0.93	0.97
Basic EPS - Continuing Operations	0.64	0.66	0.57	0.93	0.97
Basic Weighted Average Shares Outstanding	12Cr	12Cr	12Cr	12Cr	12Cr
Net EPS - Diluted	0.64	0.66	0.57	0.93	0.97
Diluted EPS - Continuing Operations	0.64	0.66	0.57	0.93	0.97
Diluted Weighted Average Shares Outstanding	12Cr	12Cr	12Cr	12Cr	12Cr
Normalized Basic EPS	0.3	0.42	0.36	0.58	0.54
Normalized Diluted EPS	0.3	0.42	0.36	0.58	0.54
Dividend Per Share	0.27	0.17	0.39	0.58	-
Payout Ratio	37.24	-	44.36	47.63	33.64
Supplemental Items
EBITDA	16Cr	28Cr	30Cr	34Cr	40Cr
EBITA	14Cr	25Cr	26Cr	30Cr	35Cr
EBIT	14Cr	25Cr	26Cr	30Cr	35Cr
EBITDAR	17Cr	29Cr	30Cr	35Cr	42Cr
Effective Tax Rate - (Ratio)	-62.3	-7.69	4.58	3.95	-7.28
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	8L	39.5L	98.38L	1.36Cr	1.31Cr
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-3.12Cr	-1Cr	-61.03L	-85.11L	-2.17Cr
Normalized Net Income	3.67Cr	5.2Cr	4.35Cr	7.17Cr	6.63Cr
Interest on Long-Term Debt	2.43Cr	3.45Cr	3.86Cr	4.53Cr	6.46Cr
Supplemental Operating Expense Items
Selling and Marketing Expenses	53Cr	61Cr	80Cr	92Cr	102.37Cr
General and Administrative Expenses	14Cr	17Cr	24Cr	30Cr	35Cr
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	48.31L	89.98L	89.07L	1.28Cr	1.31Cr
Imputed Operating Lease Interest Expense	31.86L	1.09Cr	1.06Cr	1.28Cr	1.59Cr
Imputed Operating Lease Depreciation	16.45L	-18.99L	-17.36L	1.33T	-28.23L

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	19Cr	18Cr	19Cr	23Cr	24Cr
Total Cash And Short Term Investments	19Cr	18Cr	19Cr	23Cr	24Cr
Accounts Receivable, Total	83Cr	104.35Cr	118.71Cr	139.37Cr	155.6Cr
Other Receivables	45Cr	50Cr	60Cr	54Cr	57Cr
Total Receivables	127.96Cr	154.17Cr	178.79Cr	192.96Cr	212.35Cr
Inventory	108.46Cr	123.57Cr	152.76Cr	182.05Cr	209.52Cr
Prepaid Expenses	87.24L	86.74L	1.04Cr	1.23Cr	84.84L
Other Current Assets, Total	2.05Cr	1.11Cr	1.97Cr	2.82Cr	3.17Cr
Total Current Assets	258.2Cr	298.04Cr	353.94Cr	402.01Cr	449.41Cr
Gross Property Plant And Equipment	92Cr	102.59Cr	117.87Cr	146.82Cr	99Cr
Accumulated Depreciation	-40Cr	-52Cr	-64Cr	-79Cr	-17Cr
Net Property Plant And Equipment	52Cr	51Cr	54Cr	67Cr	82Cr
Long-term Investments	-	19.93L	20.05L	20.39L	18.58L
Goodwill	50Cr	49Cr	48Cr	49Cr	48Cr
Other Intangibles, Total	13Cr	13Cr	13Cr	14Cr	16Cr
Deferred Tax Assets Long-Term	16Cr	18Cr	18Cr	23Cr	23Cr
Other Long-Term Assets, Total	14Cr	7.9Cr	5.9Cr	5.65Cr	5.12Cr
Total Assets	403.29Cr	436.49Cr	493.79Cr	561.62Cr	623.43Cr
Liabilities
Accounts Payable, Total	133.3Cr	148.56Cr	182.05Cr	219.54Cr	262.18Cr
Accrued Expenses, Total	12Cr	15Cr	17Cr	9.17Cr	25Cr
Current Portion of Long-Term Debt	12Cr	13Cr	21Cr	25Cr	31Cr
Current Portion of Leases	8.92Cr	9.09Cr	9.25Cr	11Cr	12Cr
Current Income Taxes Payable	2L	2L	22.9L	13Cr	27.05L
Unearned Revenue Current, Total	-	2.15Cr	4.94Cr	11Cr	5.44Cr
Other Current Liabilities	5.72Cr	7.95Cr	10Cr	10Cr	13Cr
Total Current Liabilities	171.69Cr	195.63Cr	244.66Cr	298.91Cr	348.49Cr
Long-Term Debt	44Cr	53Cr	57Cr	55Cr	56Cr
Long-Term Leases	30Cr	27Cr	27Cr	34Cr	41Cr
Deferred Tax Liability Non Current	3.81Cr	4.14Cr	4.02Cr	8.21Cr	5.45Cr
Other Non Current Liabilities	6.2Cr	5.43Cr	6.71Cr	7.17Cr	8.46Cr
Total Liabilities	255.7Cr	285.43Cr	339.89Cr	403.04Cr	459.87Cr
Common Stock, Total	104.37Cr	104.37Cr	104.37Cr	92Cr	105.87Cr
Retained Earnings	9.74Cr	16Cr	18Cr	22Cr	12Cr
Treasury Stock	-1.64Cr	-1.64Cr	-1.64Cr	-1.64Cr	-1.64Cr
Comprehensive Income and Other	-3.86Cr	67.44L	4.1Cr	18Cr	18Cr
Total Common Equity	108.61Cr	119.1Cr	124.83Cr	130.31Cr	134.57Cr
Minority Interest	39Cr	32Cr	29Cr	28Cr	29Cr
Total Equity	147.59Cr	151.06Cr	153.9Cr	158.58Cr	163.56Cr
Total Liabilities And Equity	403.29Cr	436.49Cr	493.79Cr	561.62Cr	623.43Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	12Cr	12Cr	12Cr	12Cr	12Cr
ECS Total Common Shares Outstanding	12Cr	12Cr	12Cr	12Cr	12Cr
Book Value / Share	8.86	9.71	10.18	10.63	10.98
Tangible Book Value	46Cr	57Cr	63Cr	67Cr	71Cr
Tangible Book Value Per Share	3.77	4.66	5.14	5.5	5.79
Total Debt	95Cr	102.42Cr	114.37Cr	124.67Cr	140.18Cr
Net Debt	76Cr	84Cr	95Cr	101.72Cr	116.67Cr
Debt Equivalent Oper. Leases	3.86Cr	7.2Cr	7.13Cr	10Cr	10Cr
Minority Interest, Total (Incl. Fin. Div)	39Cr	32Cr	29Cr	28Cr	29Cr
Equity Method Investments, Total	-	19.93L	20.05L	20.39L	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	-	-	8.14Cr	3.91Cr	3.79Cr
Inventories - Finished Goods, Total	109.11Cr	124.29Cr	145.12Cr	178.84Cr	206.62Cr
Inventories - Others	-	-	-	-	-
Machinery, Total	19Cr	22Cr	24Cr	28Cr	15Cr
Full Time Employees	7.08T	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	2.7Cr	2.85Cr	3.84Cr	3.94Cr	5.04Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	7.82Cr	8.09Cr	7.04Cr	11Cr	12Cr
Depreciation & Amortization - CF	11Cr	12Cr	13Cr	15Cr	18Cr
Amortization of Goodwill and Intangible Assets - (CF)	23T	11T	-	-	-
Depreciation & Amortization, Total	11Cr	12Cr	13Cr	15Cr	18Cr
Amortization of Deferred Charges, Total - (CF)	21.53L	30.99L	46.25L	64.49L	94.48L
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-2.89Cr	-	-	-13.61L
Asset Writedown & Restructuring Costs	1.24Cr	1.42Cr	1.22Cr	1.1Cr	1.51Cr
(Income) Loss On Equity Investments - (CF)	-59.76L	7T	-11T	-35T	2L
Provision and Write-off of Bad Debts	1.23Cr	1.08Cr	1.31Cr	1.33Cr	1.59Cr
Other Operating Activities, Total	4.4Cr	16Cr	17Cr	17Cr	22Cr
Change In Accounts Receivable	-12Cr	-22Cr	-21Cr	-25Cr	-17Cr
Change In Inventories	-15Cr	-15Cr	-29Cr	-30Cr	-30Cr
Change In Accounts Payable	19Cr	17Cr	42Cr	49Cr	39Cr
Change In Income Taxes	-3.95Cr	-2.18Cr	1.04Cr	-58.8L	1.08Cr
Change in Other Net Operating Assets	-2.56Cr	-2.08Cr	-6.29Cr	9.85Cr	-2.66Cr
Cash from Operations	11Cr	13Cr	26Cr	50Cr	46Cr
Capital Expenditure	-6.85Cr	-6Cr	-6.75Cr	-10Cr	-15Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Sale (Purchase) of Intangible assets	-1.35Cr	-1.05Cr	-1.4Cr	-2.81Cr	-2.94Cr
Investment in Marketable and Equity Securities, Total	-43.3L	4.87Cr	-1.5Cr	-62.61L	-
Cash from Investing	-8.64Cr	-2.17Cr	-9.66Cr	-14Cr	-18Cr
Long-Term Debt Issued, Total	55Cr	89Cr	108.21Cr	47Cr	102.23Cr
Total Debt Issued	55Cr	89Cr	108.21Cr	47Cr	102.23Cr
Long-Term Debt Repaid, Total	-69Cr	-90Cr	-104.73Cr	-59Cr	-103.62Cr
Total Debt Repaid	-69Cr	-90Cr	-104.73Cr	-59Cr	-103.62Cr
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-2.91Cr	-	-3.12Cr	-5.46Cr	-4Cr
Common & Preferred Stock Dividends Paid	-2.91Cr	-	-3.12Cr	-5.46Cr	-4Cr
Other Financing Activities, Total	-3.57Cr	-10Cr	-16Cr	-15Cr	-22Cr
Cash from Financing	-20Cr	-11Cr	-15Cr	-32Cr	-28Cr
Net Change in Cash	-18Cr	-52.62L	1.05Cr	3.58Cr	55.69L
Supplemental Items
Cash Interest Paid	3.57Cr	10Cr	16Cr	15Cr	19Cr
Cash Income Tax Paid (Refund)	6L	50.6L	89.26L	1.32Cr	-1.29Cr
Levered Free Cash Flow	-1.09Cr	-5.7Cr	-1.69Cr	16Cr	6.59Cr
Unlevered Free Cash Flow	3.67Cr	3.62Cr	8.43Cr	25Cr	19Cr
Change In Net Working Capital	8.07Cr	18Cr	13Cr	-3.71Cr	4.05Cr
Net Debt Issued / Repaid	-14Cr	-74.06L	3.49Cr	-12Cr	-1.39Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.19	3.78	3.51	3.55	3.69
Return on Total Capital	3.58	6.4	6.26	6.79	7.46
Return On Equity %	5.44	5.69	5.11	7.86	7.82
Return on Common Equity	7.33	7.1	5.77	8.98	8.98
Margin Analysis
Gross Profit Margin %	14.15	14.66	14.92	15	15.29
SG&A Margin	10.42	9.96	12.08	12.06	11.95
EBITDA Margin %	2.54	3.64	3.41	3.37	3.53
EBITA Margin %	2.12	3.25	3.01	2.95	3.06
EBIT Margin %	2.12	3.25	3.01	2.95	3.06
Income From Continuing Operations Margin %	1.23	1.09	0.9	1.21	1.1
Net Income Margin %	1.22	1.03	0.81	1.13	1.04
Net Avail. For Common Margin %	1.22	1.03	0.81	1.13	1.04
Normalized Net Income Margin	0.57	0.66	0.5	0.71	0.58
Levered Free Cash Flow Margin	-0.17	-0.73	-0.19	1.57	0.58
Unlevered Free Cash Flow Margin	0.57	0.46	0.97	2.49	1.67
Asset Turnover
Asset Turnover	1.65	1.86	1.86	1.92	1.93
Fixed Assets Turnover	14.07	15.24	16.62	16.79	15.28
Receivables Turnover (Average Receivables)	8.05	8.34	7.77	7.87	7.76
Inventory Turnover (Average Inventory)	5.54	5.75	5.33	5.16	4.95
Short Term Liquidity
Current Ratio	1.5	1.52	1.45	1.34	1.29
Quick Ratio	0.86	0.88	0.81	0.72	0.68
Operating Cash Flow to Current Liabilities	0.06	0.06	0.11	0.17	0.13
Days Sales Outstanding (Average Receivables)	45.34	43.78	47	46.52	47.01
Days Outstanding Inventory (Average Inventory)	65.91	63.48	68.43	70.99	73.67
Average Days Payable Outstanding	79.55	74.16	78.75	82.35	88.13
Cash Conversion Cycle (Average Days)	31.71	33.1	36.68	35.15	32.55
Long Term Solvency
Total Debt/Equity	64.16	67.8	74.31	78.62	85.71
Total Debt / Total Capital	39.08	40.41	42.63	44.01	46.15
LT Debt/Equity	50.14	53.11	54.9	55.96	59.59
Long-Term Debt / Total Capital	30.55	31.65	31.49	31.33	32.09
Total Liabilities / Total Assets	63.4	65.39	68.83	71.76	73.76
EBIT / Interest Expense	1.79	1.7	1.61	2.01	1.74
EBITDA / Interest Expense	3.26	2.53	2.43	3.03	2.63
(EBITDA - Capex) / Interest Expense	2.36	2.13	2.02	2.34	1.91
Total Debt / EBITDA	3.81	2.71	2.9	2.75	2.64
Net Debt / EBITDA	3.05	2.22	2.41	2.25	2.2
Total Debt / (EBITDA - Capex)	5.26	3.22	3.5	3.56	3.66
Net Debt / (EBITDA - Capex)	4.21	2.64	2.91	2.91	3.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17	21.88	10.82	17.22	12.77
Gross Profit, 1 Yr. Growth %	18.86	26.22	12.78	17.87	14.95
EBITDA, 1 Yr. Growth %	8.54	74.65	8.16	15.73	18.21
EBITA, 1 Yr. Growth %	6.23	86.25	7.47	14.76	16.85
EBIT, 1 Yr. Growth %	6.22	86.27	7.48	14.76	16.85
Earnings From Cont. Operations, 1 Yr. Growth %	28.02	7.49	-8.45	57.74	2.61
Net Income, 1 Yr. Growth %	49.41	3.43	-12.95	62.76	3.77
Normalized Net Income, 1 Yr. Growth %	97.64	41.45	-3.66	64.65	-7.51
Diluted EPS Before Extra, 1 Yr. Growth %	49.41	3.43	-12.98	62.72	3.82
Accounts Receivable, 1 Yr. Growth %	9.12	25.51	13.76	17.4	11.64
Inventory, 1 Yr. Growth %	20	13.92	23.63	19.17	15.09
Net Property, Plant and Equip., 1 Yr. Growth %	32.19	-2.32	5.64	25.88	22.27
Total Assets, 1 Yr. Growth %	7.23	8.23	13.13	13.74	11
Tangible Book Value, 1 Yr. Growth %	9.46	23.78	10.31	6.87	5.33
Common Equity, 1 Yr. Growth %	3.8	9.66	4.81	4.39	3.27
Cash From Operations, 1 Yr. Growth %	173.42	17.43	106.53	90.53	-7.52
Capital Expenditures, 1 Yr. Growth %	90.13	-12.52	12.64	51.83	43.12
Levered Free Cash Flow, 1 Yr. Growth %	-57.07	424.82	-73.59	-1.05T	-58.77
Unlevered Free Cash Flow, 1 Yr. Growth %	120.04	-1.43	186.62	200.24	-24.31
Dividend Per Share, 1 Yr. Growth %	-	-35.94	122.58	49.05	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.57	19.41	16.22	13.98	14.98
Gross Profit, 2 Yr. CAGR %	10.91	22.48	19.31	15.3	16.4
EBITDA, 2 Yr. CAGR %	13.4	37.68	34.79	11.88	16.96
EBITA, 2 Yr. CAGR %	13.66	40.66	38.43	11.06	15.8
EBIT, 2 Yr. CAGR %	13.67	40.66	38.44	11.06	15.8
Earnings From Cont. Operations, 2 Yr. CAGR %	157	17.31	-0.8	20.17	27.22
Net Income, 2 Yr. CAGR %	155.5	24.31	-5.12	19.03	29.96
Normalized Net Income, 2 Yr. CAGR %	255.26	67.2	8.85	25.94	23.41
Diluted EPS Before Extra, 2 Yr. CAGR %	155.5	24.31	-5.13	19	29.98
Accounts Receivable, 2 Yr. CAGR %	22.57	17.03	19.49	15.57	14.49
Inventory, 2 Yr. CAGR %	9.92	16.92	18.68	21.38	17.11
Net Property, Plant and Equip., 2 Yr. CAGR %	29.22	13.64	1.58	15.31	24.06
Total Assets, 2 Yr. CAGR %	12.55	7.73	10.65	13.43	12.36
Tangible Book Value, 2 Yr. CAGR %	10.84	16.4	16.85	8.58	6.1
Common Equity, 2 Yr. CAGR %	3.97	6.69	7.21	4.6	3.83
Cash From Operations, 2 Yr. CAGR %	-8.18	79.18	55.73	98.37	32.74
Capital Expenditures, 2 Yr. CAGR %	78.81	28.97	-0.73	30.77	47.41
Levered Free Cash Flow, 2 Yr. CAGR %	-36.1	50.1	24.54	58.23	97.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	7.84	47.27	51.52	193.35	50.74
Dividend Per Share, 2 Yr. CAGR %	-	-	19.41	82.14	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.51	17.64	16.48	16.55	13.57
Gross Profit, 3 Yr. CAGR %	10.05	15.79	19.16	18.83	15.18
EBITDA, 3 Yr. CAGR %	29.37	30.96	25.4	28.11	13.95
EBITA, 3 Yr. CAGR %	35.56	34	26.73	30.04	12.95
EBIT, 3 Yr. CAGR %	35.58	34.01	26.74	30.04	12.95
Earnings From Cont. Operations, 3 Yr. CAGR %	101.06	92.2	8.01	15.79	14.01
Net Income, 3 Yr. CAGR %	100.27	89.01	10.39	13.58	13.71
Normalized Net Income, 3 Yr. CAGR %	27.62	161.35	32.8	24.95	13.63
Diluted EPS Before Extra, 3 Yr. CAGR %	97.25	89.01	10.38	13.56	13.71
Accounts Receivable, 3 Yr. CAGR %	15.1	23.54	15.93	18.79	14.24
Inventory, 3 Yr. CAGR %	10.9	11.24	19.12	18.84	19.25
Net Property, Plant and Equip., 3 Yr. CAGR %	59.09	17.71	10.91	9.11	17.59
Total Assets, 3 Yr. CAGR %	11.75	11.1	9.5	11.67	12.62
Tangible Book Value, 3 Yr. CAGR %	9.67	14.99	14.33	13.42	7.48
Common Equity, 3 Yr. CAGR %	2.07	5.84	6.06	6.26	4.16
Cash From Operations, 3 Yr. CAGR %	24.43	-0.34	87.87	66.56	53.82
Capital Expenditures, 3 Yr. CAGR %	78.34	40.9	23.28	14.37	34.76
Levered Free Cash Flow, 3 Yr. CAGR %	-8.38	28.92	-12.68	144.98	1.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	10.09	4.66	71.59	90.32	86.75
Dividend Per Share, 3 Yr. CAGR %	-	-	-	28.57	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.44	13.77	15.19	16.16	15.87
Gross Profit, 5 Yr. CAGR %	7.74	10.32	13.67	15.59	18.05
EBITDA, 5 Yr. CAGR %	9.96	64.86	31.52	22.01	21.96
EBITA, 5 Yr. CAGR %	10.76	99.01	36.7	23.22	22.24
EBIT, 5 Yr. CAGR %	10.76	99.01	36.71	23.23	22.24
Earnings From Cont. Operations, 5 Yr. CAGR %	10.07	-5.48	51.57	59.28	15.32
Net Income, 5 Yr. CAGR %	9.81	-6.42	48.54	57.09	17.84
Normalized Net Income, 5 Yr. CAGR %	2.32	-11.55	19.75	89.79	28.96
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.95	-15.82	47.19	57.07	17.84
Accounts Receivable, 5 Yr. CAGR %	9.54	17.63	16.84	20.29	15.35
Inventory, 5 Yr. CAGR %	10.8	14.41	13.95	15.19	18.31
Net Property, Plant and Equip., 5 Yr. CAGR %	35.88	30.1	32.96	16.75	15.99
Total Assets, 5 Yr. CAGR %	8.26	10.75	11.31	12.02	10.64
Tangible Book Value, 5 Yr. CAGR %	68.61	54.92	12.49	12.38	10.96
Common Equity, 5 Yr. CAGR %	7.43	9.81	4.1	5.34	5.16
Cash From Operations, 5 Yr. CAGR %	0.05	19.5	36.11	31.25	63.5
Capital Expenditures, 5 Yr. CAGR %	19.54	4.66	41.08	36.76	32.42
Levered Free Cash Flow, 5 Yr. CAGR %	-34.72	-16.65	3.59	43.11	21.08
Unlevered Free Cash Flow, 5 Yr. CAGR %	38.94	-1.84	25.1	51.63	62.93